Bryan joined Venrock as a Kauffman Fellow in 1997. He is based in Palo Alto and invests broadly across the healthcare industry. Bryan is currently Chairman of the Board of Directors of Castlight Health (NYSE: CSLT) and Achaogen (NASDAQ: AKAO). He also serves on the Board of several private companies, including 10X Genomics, Doctor on Demand, Grand Rounds, Hua Medicine, Intarcia and Lyra Health and is a Board observer at CloudFlare. Past investments include Ariosa Diagnostics (acquired by Roche), athenahealth (NASDAQ: ATHN), Ikaria (acquired by Mallinkrodt), Illumina (NASDAQ: ILMN), Receptos (acquired by Celgene), Vitae Pharmaceuticals (acquired by Allergan), Ironwood Pharmaceuticals (NASDAQ: IRWD), Sirna Therapeutics (acquired by Merck) and Zeltiq (NASDAQ: ZLTQ). Bryan was named a Henry Crown Fellow by the Aspen Institute in 2006 and has ranked on Forbes’ Midas List nine times, 2008 – 2017.
Immediately prior to joining Venrock, Bryan received his Ph.D. in Chemistry & Chemical Biology from Harvard University. He received his B.A. from Dartmouth College.